TY - CHAP
T1 - PET Visualization of Brain Tau Accumulations Secondary to Various CNS Injuries
T2 - Chronic Traumatic Encephalopathy (CTE) and Organophosphorus Poisoning
AU - Takahata, Keisuke
AU - Moriguchi, Sho
AU - Suzuki, Hisaomi
AU - Kurose, Shin
AU - Momota, Yuki
AU - Tagai, Kenji
AU - Endo, Hironobu
AU - Kataoka, Yuko
AU - Ichihashi, Masanori
AU - Komatsu, Yuki
AU - Anamizu, Sachiko
AU - Sahara, Naruhiko
AU - Higuchi, Makoto
N1 - Publisher Copyright:
© The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature 2025.
PY - 2025
Y1 - 2025
N2 - Traumatic brain injury (TBI) can lead to severe and persistent neuropsychiatric sequelae. Recent clinical and neuropathological studies have elucidated the epidemiological link between TBI and the subsequent development of neurodegenerative diseases. Chronic traumatic encephalopathy (CTE), a neurodegenerative disorder associated with repeated mild TBI, is characterized by the deposition of hyperphosphorylated tau in neurofibrillary and astrocytic tangles, predominantly surrounding small blood vessels in the cortical sulci. Recent cryo-electron microscopy (cryo-EM) studies have shown that CTE-type tau folds appear in the brain long after the onset of some central nervous system diseases. In addition to TBI-related tauopathies, emerging evidence suggests that exposure to organophosphorus compounds, such as pesticides and nerve agents, may also contribute to long-term neuropsychiatric sequelae, including cognitive impairment and psychiatric disorders, and has been postulated to promote neuropathological changes including tau accumulation through persistent neuroinflammation and excitotoxicity. Positron emission tomography (PET) has emerged as a valuable tool for detecting molecular pathologies in neurodegenerative diseases. This review focuses on the development of tau PET tracers for in vivo visualization of tau deposition in chronic TBI states. We present current findings from tau PET imaging studies on CTE and other secondary tauopathies, utilizing both first- and second-generation tau PET tracers. Additionally, we discuss PET quantification techniques for assessing tau burden in the chronic stages of TBI, with particular emphasis on the unique topography of tau lesions in CTE.
AB - Traumatic brain injury (TBI) can lead to severe and persistent neuropsychiatric sequelae. Recent clinical and neuropathological studies have elucidated the epidemiological link between TBI and the subsequent development of neurodegenerative diseases. Chronic traumatic encephalopathy (CTE), a neurodegenerative disorder associated with repeated mild TBI, is characterized by the deposition of hyperphosphorylated tau in neurofibrillary and astrocytic tangles, predominantly surrounding small blood vessels in the cortical sulci. Recent cryo-electron microscopy (cryo-EM) studies have shown that CTE-type tau folds appear in the brain long after the onset of some central nervous system diseases. In addition to TBI-related tauopathies, emerging evidence suggests that exposure to organophosphorus compounds, such as pesticides and nerve agents, may also contribute to long-term neuropsychiatric sequelae, including cognitive impairment and psychiatric disorders, and has been postulated to promote neuropathological changes including tau accumulation through persistent neuroinflammation and excitotoxicity. Positron emission tomography (PET) has emerged as a valuable tool for detecting molecular pathologies in neurodegenerative diseases. This review focuses on the development of tau PET tracers for in vivo visualization of tau deposition in chronic TBI states. We present current findings from tau PET imaging studies on CTE and other secondary tauopathies, utilizing both first- and second-generation tau PET tracers. Additionally, we discuss PET quantification techniques for assessing tau burden in the chronic stages of TBI, with particular emphasis on the unique topography of tau lesions in CTE.
KW - Biomarker
KW - Chronic traumatic encephalopathy
KW - Concussion
KW - Florzolotau
KW - Organophosphorus
KW - Positron emission tomography
KW - Secondary tauopathy
KW - Tau
KW - Traumatic brain injury
UR - https://www.scopus.com/pages/publications/105004351724
UR - https://www.scopus.com/pages/publications/105004351724#tab=citedBy
U2 - 10.1007/978-1-0716-4494-2_4
DO - 10.1007/978-1-0716-4494-2_4
M3 - Chapter
AN - SCOPUS:105004351724
T3 - Neuromethods
SP - 45
EP - 65
BT - Neuromethods
PB - Humana Press Inc.
ER -